Parkinson’s Disease and Related Diseases: Mechanisms, Genetic Factors and Treatments
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 879
Special Issue Editor
2. Department of Medical Oncology, Ioannina University Hospital, 455 00 Ioannina, Greece
3. Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK
4. Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK
5. Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, Kent, UK
6. AELIA Organization, 9th Km Thessaloniki—Thermi, 57001 Thessaloniki, Greece
Interests: prostate cancer; renal cancer; ovarian cancer; homologous recombination of DNA; PARP inhibitors; cervical cancer; carcinoma of unknown primary; colorectal cancer; cancer and autoimmune diseases; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Parkinson’s disease (PD) and related neurodegenerative disorders pose a growing global health challenge, affecting millions with progressive motor and cognitive decline. Despite extensive research, the precise molecular mechanisms underlying PD remain elusive, with genetic and environmental interactions playing critical roles. Understanding the pathophysiology of PD—including emerging insights into α-synuclein aggregation, mitochondrial dysfunction, neuroinflammation, and novel genetic risk factors—is of paramount importance.
A pressing concern is the variability in disease progression and treatment response, highlighting the need for personalized therapeutic strategies. While current treatments offer symptom management, breakthroughs in gene therapy, neuroprotective agents, and precision medicine are reshaping the landscape. Additionally, the integration of machine learning and artificial intelligence in predicting disease onset, progression, and treatment outcomes holds transformative potential. We invite original research and comprehensive reviews that uncover novel molecular targets, refine diagnostic biomarkers, and advance AI-driven predictive models to revolutionize PD care and improve patient outcomes.
Guiding this exploration are Professor Stergios Boussios and Dr. David Olawade (University of East London), whose expertise is crucial in this Special Issue.
Prof. Dr. Stergios Boussios
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Parkinson’s disease
- neurodegenerative disorders
- α-synuclein aggregation
- neuroinflammation
- gene therapy
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
